Cargando…
Francisella tularensis Vaccines Elicit Concurrent Protective T- and B-Cell Immune Responses in BALB/cByJ Mice
In the last decade several new vaccines against Francisella tularensis, which causes tularemia, have been characterized in animal models. Whereas many of these vaccine candidates showed promise, it remains critical to bridge the preclinical studies to human subjects, ideally by taking advantage of c...
Autores principales: | De Pascalis, Roberto, Mittereder, Lara, Chou, Alicia Y., Kennett, Nikki J., Elkins, Karen L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431730/ https://www.ncbi.nlm.nih.gov/pubmed/25973794 http://dx.doi.org/10.1371/journal.pone.0126570 |
Ejemplares similares
-
IL-12p40 is essential but not sufficient for Francisella tularensis LVS clearance in chronically infected mice
por: Mittereder, Lara R., et al.
Publicado: (2023) -
Models Derived from In Vitro Analyses of Spleen, Liver, and Lung Leukocyte Functions Predict Vaccine Efficacy against the Francisella tularensis Live Vaccine Strain (LVS)
por: De Pascalis, Roberto, et al.
Publicado: (2014) -
A panel of correlates predicts vaccine-induced protection of rats against respiratory challenge with virulent Francisella tularensis
por: De Pascalis, Roberto, et al.
Publicado: (2018) -
Production of IFN-γ by splenic dendritic cells during innate immune responses against Francisella tularensis LVS depends on MyD88, but not TLR2, TLR4, or TLR9
por: De Pascalis, Roberto, et al.
Publicado: (2020) -
Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunity
por: Kurtz, Sherry L., et al.
Publicado: (2021)